Cytek Biosciences Inc (CTKB)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue (ttm)	US$ in thousands	176,629	201,210	197,710	200,786	193,014	183,117	175,594	166,060	164,036	154,594	148,493	138,742	127,950	119,675	110,395	99,123	92,839
Property, plant and equipment	US$ in thousands	—	—	—	—	—	—	15,588	15,549	13,682	7,844	7,340	6,504	5,851	4,982	3,895	2,476	—
Fixed asset turnover		—	—	—	—	—	—	11.26	10.68	11.99	19.71	20.23	21.33	21.87	24.02	28.34	40.03	—

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $176,629K ÷ $—K
= —

Fixed asset turnover is a financial ratio that measures a company's ability to generate sales from its investments in fixed assets. Cytek Biosciences Inc's fixed asset turnover has fluctuated over the past few years, with a general downward trend.

As of September 30, 2022, the fixed asset turnover was 19.71, indicating that for every dollar invested in fixed assets, the company generated approximately $19.71 in sales. The ratio decreased to 11.99 by December 31, 2022, signaling a decline in the efficiency of utilizing fixed assets to generate revenue.

The trend continued into the following periods, with the fixed asset turnover falling to 10.68 as of March 31, 2023, before slightly increasing to 11.26 by June 30, 2023. The ratio data is not available for the subsequent periods, indicating a lack of information for a comprehensive analysis.

Overall, the decreasing trend in fixed asset turnover may suggest potential issues with asset utilization efficiency or a need for strategic capital investments to enhance productivity and profitability in the future. It is important for Cytek Biosciences Inc to closely monitor and improve its fixed asset turnover to ensure optimal performance and sustainable growth.